REGENXBIO Inc. (22) | Intellectual Property (4)
- Fifth Amendment to License Agreement effective September 11, 2020 between the Company and The Trustees of the University of Pennsylvania (Filed With SEC on November 4, 2020)
- First Amendment to License Agreement dated November 4, 2019 between the Registrant and Abeona Therapeutics Inc (Filed With SEC on February 26, 2020)
- Fourth Amendment to License Agreement effective April 4, 2019 between the Company and The Trustees of the University of Pennsylvania (Filed With SEC on May 7, 2019)
- License Agreement dated November 4, 2018 between the Registrant and Abeona Therapeutics Inc (Filed With SEC on February 27, 2019)
